Iradimed (IRMD) Capital Expenditures (2013 - 2026)

Iradimed (IRMD) has 14 years of Capital Expenditures data on file, last reported at $403000.0 in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $403000.0, down 89.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 123.08% YoY), and the FY2025 annual result was $656000.0, down 91.81% from the prior year.
• Capital Expenditures rose to $403000.0 in Q1 2026 per IRMD's latest filing, from -$6.8 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $6.4 million in Q1 2023 and troughed at -$6.8 million in Q4 2025.
• A 5-year average of $628390.3 and a median of $270566.0 in 2024 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures sank 3314.03% in 2023, then surged 3620.2% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $213540.0 in 2022, then slumped by 52.74% to $100913.0 in 2023, then surged by 2664.9% to $2.8 million in 2024, then tumbled by 344.25% to -$6.8 million in 2025, then soared by 105.91% to $403000.0 in 2026.
• Business Quant data shows IRMD's Capital Expenditures at $403000.0 in Q1 2026, -$6.8 million in Q4 2025, and $1.1 million in Q3 2025.